Biocompatibility and drug delivery systems
Daniel S. Kohane, Róbert Langer
Abstract
Daniel S. Kohane, Róbert Langer
Abstract
Drug delivery technology has emerged as an important focus of biotechnological research and commercial enterprise. While much attention is justifiably focused on the design and effectiveness of drug delivery devices, the nature of their interaction with surrounding tissues – their biocompatibility – is crucial. Here we discuss biocompatibility, specifically as it relates to drug delivery systems, which differ from other biomaterial-based devices by possibly containing large quantities of drugs with their own effects on tissues.
OpenAlex reports 304 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Drug delivery technology has emerged as an important focus of biotechnological research and commercial enterprise. While much attention is justifiably focused on the design and effectiveness of drug delivery devices, the nature of their interaction with surrounding tissues – their biocompatibility – is crucial. Here we discuss biocompatibility, specifically as it relates to drug delivery systems, which differ from other biomaterial-based devices by possibly containing large quantities of drugs with their own effects on tissues.
Key concepts: Biocompatibility, Drug delivery, Drug, Nanotechnology, Biomaterial, Biocompatible material, Biomedical engineering, Pharmacology